Skip navigation



Astex’s Harren Jhoti made Fellow of the Royal Society

Cambridge, UK - Astex Pharmaceuticals (“Astex”), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics for oncology and diseases of the central nervous system, announced today that Harren Jhoti Ph.D., co-founder of Astex and President and CEO of Astex Pharmaceuticals (UK) has been elected a Fellow of the Royal Society in recognition of his outstanding contribution to drug discovery research and science in general. More »
09 May 2018

ACTION NEEDED TO SUSTAIN GROWTH IN Cambridgeshire & Peterborough

The Cambridgeshire and Peterborough Independent Economic Review (CPIER) has today published its interim report, which has been developed by the Cambridgeshire and Peterborough Independent Economic Commission (CPIEC). More »
09 May 2018

TTP plc and Camena Bioscience Partner to Create Novel Metabolite Analyser

More »
09 May 2018

Horizon Discovery appoints Terry Pizzie as Chief Executive Officer

Horizon Discovery Group plc is pleased to announce the appointment of Terry Pizzie as Chief Executive Officer and Board Director with immediate effect. More »
08 May 2018

ELIXIR maps for the first time how small and medium companies rely on public bioinformatics data for their business

ELIXIR, the European Life-science Infrastructure for Biological Information, published a report that describes the use of public bioinformatics data by Small to Medium-sized Companies (SMEs) in Europe. Through analysing the business models of seven European SMEs, including two companies based in Cambridgeshire (Eagle Genomics & Repositive), the report systematically maps the ways open life-science data contribute to innovation and generate business value. More »
08 May 2018

Cambridge Life Sciences Cluster Set to Deliver an Additional £1 billion to the UK Economy by 2032

The Cambridge life sciences cluster has the potential to contribute an additional £1bn to the UK economy by 2032, according to independent research commissioned by AstraZeneca. More »
04 May 2018

Cambridge Biomedical Campus Laboratory Relocation Win

Laboratory relocation specialist Premier Workplace Services has won the contract to project manage and deliver the relocation of global life science e-commerce company Abcam from three existing sites into a new state-of-the-art global headquarters on the Cambridge Biomedical Campus. More »
02 May 2018

NeoPhore and PhoreMost to receive Grant Award of £1 Million for Innovative Drug Discovery Programme

NeoPhore and PhoreMost Receive Innovate UK Funding to Support Development of a Novel Small-Molecule Cancer Immunotherapy Programme More »
02 May 2018

Isogenic Cell Lines for Cancer Research - AMSBIO

AMSBIO has introduced a new range of over 400 Isogenic cell lines that provide a reliable and efficient alternative to traditional human disease models. More »
02 May 2018

IONTAS and aTen Therapeutics Announce Collaboration to Discover Therapeutic Oncology Leads

IONTAS Limited (IONTAS), a leader in the discovery and optimisation of fully human antibodies, and aTen Therapeutics Limited (aTen), a private biopharmaceutical company developing next-generation antibodies for the treatment of cancer, announced today that they have entered into a strategic collaboration. Under the agreement IONTAS will use its proprietary antibody discovery platforms to deliver antibodies against biological targets selected by aTen. More »
02 May 2018

<< Previous   Page 1 of 38   Next >>